Zim Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ZIMLAB BSE: 541400

About Zim Laboratories Limited

No company profile on record yet.

Key facts

BSE symbol541400
NSE symbolZIMLAB
ISININE518E01015
CINL99999MH1984PLC032172
Listing date25 Nov 2022
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorBNP & Associates (Avinash Bagul)
Registered officeSadoday Gyan (Ground Floor), Opposite - NADT, Nelson Square, Nagpur - 440013.
Registrar & transfer agentMUFG Intime India Private Limited C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West) Mumbai 400083, Maharashtra

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)382†—370†403†334†
Net profit61217†25†13†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Anwar DaudExecutive DirectorJune 30, 2026
Niraj Pukhraj DhadiwalExecutive DirectorJune 30, 2026
Prakash Pralahadrao SapkalExecutive DirectorJune 30, 2026
Zulfiquar Murtuza KamalExecutive DirectorJune 30, 2026
Ashok BhatiaIndependent DirectorJune 30, 2026
Kamlesh Bajirao ShendeIndependent DirectorJune 30, 2026
Kavita LoyaIndependent DirectorJune 30, 2026
Padmakar Shrinivas JoshiIndependent DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.